Evidence map›Paper›PMID 42232765›Full record

ArticleBiochemistry and biophysics reports2026

Genomic insights into the tunicamycin-induced endoplasmic reticulum stress response in peripheral blood mononuclear cells: A comprehensive RNA sequencing analysis.

Laura S Mahl, Axel H Meyer

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Laura S MahlDepartment of QTAS, AbbVie Deutschland GmbH & Co. KG, Knollstraße 50, Ludwigshafen am Rhein, 67061, Germany.
Axel H MeyerDepartment of QTAS, AbbVie Deutschland GmbH & Co. KG, Knollstraße 50, Ludwigshafen am Rhein, 67061, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tunicamycin induces endoplasmic reticulum (ER) stress by inhibiting N-glycosylation of newly synthesized proteins, leading to accumulation of misfolded proteins in the ER. This activates the unfolded protein response (UPR), a conserved adaptive pathway aimed at restoring proteostasis. A key mediator of this response is the kinase PERK which activates a signal cascade that leads to a global reduction in translation, while selectively enhancing the expression of stress-associated genes. This PERK-mediated response also constitutes a major arm of the integrated stress response (ISR). Under persistent ER stress, these response pathways may trigger pro-apoptotic programs in addition to adaptive responses. In this study, we used next-generation RNA sequencing to profile transcriptional changes in peripheral blood mononuclear cells (PBMCs) after 24 h of tunicamycin exposure, alone or with the PERK inhibitor GSK2606414 or the eIF2B activator ISRIB, to assess stress responses at distinct regulatory points within the PERK-ISR pathway. Key findings were validated by qRT-PCR, and pathway enrichment analysis was performed using the Gene Ontology Resource and the Reactome database. ER stress altered gene expression, with 4.80% of genes upregulated and 12.67% downregulated. GSK2606414 suppressed a broader subset of tunicamycin-induced genes than ISRIB. However, both inhibitors effectively reversed upregulation of the top two stress-responsive genes, TNC and WNT5A. Pathway enrichment analysis revealed overrepresentation of pathways related to ER stress responses, unfolded protein homeostasis, ER chaperone complex assembly, amino acid biosynthesis and interconversion, and aminoacyl-tRNA synthetase-mediated protein translation. These findings provide mechanistic insights into chronic ER stress in PBMCs and identify WNT5A and TNC as candidate biomarkers, pending further validation.

Indexed as

eIF2αER stressISRPBMCsPERKTranscriptomicsTunicamycinUPR

Identifiers

PMID42232765
PMCPMC13223995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.